Suppr超能文献

正向调节剂PNU-120596对α7烟碱型乙酰胆碱受体的作用机制。

Mode of action of the positive modulator PNU-120596 on α7 nicotinic acetylcholine receptors.

作者信息

Szabo Anett K, Pesti Krisztina, Mike Arpad, Vizi E Sylvester

机构信息

Semmelweis University, School of Ph.D. Studies, Üllői út 26, H-1085 Budapest, Hungary; Laboratory of Molecular Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, P.O.B. 67, H-1450 Budapest, Hungary.

Laboratory of Molecular Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, P.O.B. 67, H-1450 Budapest, Hungary.

出版信息

Neuropharmacology. 2014 Jun;81:42-54. doi: 10.1016/j.neuropharm.2014.01.033. Epub 2014 Jan 31.

Abstract

We investigated the mode of action of PNU-120596, a type II positive allosteric modulator of the rat α7 nicotinic acetylcholine receptor expressed by GH4C1 cells, using patch-clamp and fast solution exchange. We made two important observations: first, while PNU-120596 rapidly associated to desensitized receptors, it had at least hundredfold lower affinity to resting conformation, therefore at 10 μM concentration it dissociated from resting receptors; and second, binding of PNU-120596 slowed down dissociation of choline molecules from the receptor radically. We propose that when agonist concentration is transiently elevated in the continuous presence of the modulator (as upon the neuronal release of acetylcholine in a modulator-treated animal) these two elements together cause occurrence of a cycle of events: Binding of the modulator is limited in the absence of the agonist. When the agonist is released, it binds to the receptor, and induces desensitization, thereby enabling modulator binding. Modulator binding in turn traps the agonist within its binding site for a prolonged period of time. Once the agonist finally dissociated, the modulator can also dissociate without re-binding, and the receptor assumes its original resting conformation. In kinetic simulations this "trapped agonist cycle" mechanism did not require that the orthosteric and allosteric ligands symmetrically modify each other's affinity, only the modulator must decrease agonist accessibility, and the agonist must induce a conformation that is accessible to the modulator. This mechanism effectively prolongs and amplifies the effect of the agonist.

摘要

我们使用膜片钳和快速溶液交换技术,研究了由GH4C1细胞表达的大鼠α7烟碱型乙酰胆碱受体的II型正变构调节剂PNU-120596的作用模式。我们有两个重要发现:第一,虽然PNU-120596能迅速与脱敏受体结合,但其与静息构象的亲和力至少低百倍,因此在10 μM浓度下它会从静息受体上解离;第二,PNU-120596的结合极大地减缓了胆碱分子从受体上的解离。我们提出,当在调节剂持续存在的情况下激动剂浓度短暂升高时(如在经调节剂处理的动物中神经元释放乙酰胆碱时),这两个因素共同导致一系列事件的循环发生:在没有激动剂时,调节剂的结合受到限制。当激动剂释放时,它与受体结合,并诱导脱敏,从而使调节剂能够结合。调节剂的结合反过来会将激动剂长时间困在其结合位点内。一旦激动剂最终解离,调节剂也可以解离而不再重新结合,受体恢复其原来的静息构象。在动力学模拟中,这种“被困激动剂循环”机制并不要求正构和变构配体对称地改变彼此的亲和力,只需要调节剂必须降低激动剂的可及性,并且激动剂必须诱导出调节剂可及的构象。这种机制有效地延长并放大了激动剂的作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验